Myeloma Trial, Recruiting (NCT07390071)

Myeloma Trial, Recruiting NCT07390071 Sponsor: University of Utah Condition: Myeloma

Printed from Voxsanity (voxsanity.com.au) — NCT07390071 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myeloma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be older than 21 years of age.
You must have been diagnosed with lymphoma or myeloma.
You must have a CAR-T cell therapy treatment (an FDA-approved cancer treatment) scheduled to begin at least 4 weeks after joining the trial.
You must be well enough to carry out basic daily activities, with little to no limitation due to your illness (confirm with trial site).
You must have access to a working landline or mobile phone at home.

Who may not be able to join:

You may not be able to join if you have unstable chest pain, uncontrolled high blood pressure, a recent heart attack, a pacemaker, painful or unstable bone tumors, or a recent bone fracture.
You may not be able to join if you are already taking part in a regular structured exercise or rehabilitation program.
You may not be able to join if you are planning to move or relocate within the next 6 months.
You may not be able to join if you are currently participating in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Douglas Sborov, MD, MS, Huntsman Cancer Institute/ University of Utah

Phone: 801-585-3229

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07390071

Sponsor: University of Utah

Phase: Not Applicable

Status: Recruiting

Condition: Myeloma

Trial contact: 801-585-3229

More information: https://clinicaltrials.gov/study/NCT07390071

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be older than 21 years of age.
You must have been diagnosed with lymphoma or myeloma.
You must have a CAR-T cell therapy treatment (an FDA-approved cancer treatment) scheduled to begin at least 4 weeks after joining the trial.
You must be well enough to carry out basic daily activities, with little to no limitation due to your illness (confirm with trial site).
You must have access to a working landline or mobile phone at home.

Who may not be able to join:

You may not be able to join if you have unstable chest pain, uncontrolled high blood pressure, a recent heart attack, a pacemaker, painful or unstable bone tumors, or a recent bone fracture.
You may not be able to join if you are already taking part in a regular structured exercise or rehabilitation program.
You may not be able to join if you are planning to move or relocate within the next 6 months.
You may not be able to join if you are currently participating in another clinical trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Utah

Registry

ClinicalTrials.gov

Start date

1 September 2025

Est. completion

1 January 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

System Usability Score - Feasibility; Adherence Indicators - Feasibility

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov